Evaluation of Abnormal Liver Function Tests in Pregnancy BETA
Interactive clinical decision support for evaluating abnormal liver tests in pregnancy. This tool helps organize the differential for intrahepatic cholestasis of pregnancy (ICP), HELLP syndrome, acute fatty liver of pregnancy (AFLP), hyperemesis gravidarum, and important nonpregnancy causes such as viral hepatitis, biliary disease, ischemic injury, drug-induced liver injury, NAFLD / MASLD, alcohol-related disease, chronic hepatitis, autoimmune hepatitis, and gallstones.
Calculator Inputs
Interpretation
Ready to calculate
Enter available clinical and laboratory data, then press Calculate. The tool will summarize the likely injury pattern, flag emergency concerns, suggest the leading differential, and provide next-step teaching guidance.
Visible Clinical Algorithm: Abnormal LFTs in Pregnancy
Start here
Abnormal AST, ALT, bilirubin, bile acids, or concerning symptoms in pregnancy should trigger structured review of severity, pattern, timing, and pregnancy-specific diagnoses.
Step 1. Look for red flags first
Step 2. Identify the dominant pattern
Step 3. Follow the likely branch
Practical branch summary
- 1st trimester + severe nausea/vomiting + mild AST/ALT rise → consider hyperemesis gravidarum
- 2nd or 3rd trimester + pruritus + bile acids elevated → consider ICP
- 3rd trimester/postpartum + HTN + thrombocytopenia → consider HELLP
- Late pregnancy + hypoglycemia/coagulopathy/encephalopathy → consider AFLP
- Very high aminotransferases → broaden to hepatitis / toxic / ischemic causes
- Mild persistent or chronic abnormalities → consider MASLD/NAFLD, alcohol-related liver disease, chronic hepatitis, autoimmune hepatitis, or gallstones
Suggested next tests
- CBC with platelets
- Comprehensive metabolic panel
- LDH
- Creatinine and glucose
- PT/INR ± fibrinogen if severe disease suspected
- Total bile acids
- Peripheral smear / haptoglobin / bilirubin fractionation
- Hepatitis testing when indicated
- Medication and acetaminophen review
- RUQ ultrasound if biliary disease suspected
- Consider chronic liver disease / autoimmune workup when the pattern is persistent or unexplained
Interactive Yes/No Algorithm Wizard
Start: Does the patient have any major red-flag features?
Wizard output
Diagnostic Criteria at a Glance
Complete HELLP is commonly summarized with hemolysis, elevated AST, elevated LDH, and thrombocytopenia.
| Component | Typical diagnostic level | Clinical note |
|---|---|---|
| Platelets | < 100,000 /µL | Low platelet count is central to diagnosis. |
| AST | ≥ 70 U/L | ALT is often also elevated. |
| LDH | > 600 U/L | Supports hemolysis and tissue injury. |
| Hemolysis evidence | Schistocytes, low haptoglobin, indirect bilirubin elevation | Supports the “H” in HELLP. |
Class 1: platelets ≤ 50,000/µL
Class 2: platelets 50,000–100,000/µL
Class 3: platelets 100,000–150,000/µL
AST/ALT elevation and LDH ≥ 600 U/L remain supportive.
AFLP is supported when 6 or more criteria are present in the absence of another explanation.
| Criterion | Threshold / finding |
|---|---|
| Vomiting | Present |
| Abdominal pain | Present |
| Polydipsia / polyuria | Present |
| Encephalopathy | Present |
| Bilirubin | > 0.8 mg/dL |
| Glucose | < 72 mg/dL |
| Uric acid | > 5.7 mg/dL |
| Leukocytosis | > 11 × 109/L |
| Ultrasound | Ascites or bright liver |
| AST or ALT | > 42 U/L |
| Ammonia | > 47 µmol/L |
| Creatinine | > 1.7 mg/dL |
| Coagulopathy | PT > 14 sec or aPTT > 34 sec |
| Liver biopsy | Microvesicular steatosis |
Teaching Module
1. Normal liver test changes in pregnancy +
AST, ALT, bilirubin, and PT/INR are generally not physiologically elevated in normal pregnancy. A rise in aminotransferases should be evaluated. Alkaline phosphatase can increase in later pregnancy because of placental production, so isolated ALP elevation is less specific for hepatobiliary disease.
| Laboratory test | Typical pregnancy change | Clinical pearl |
|---|---|---|
| AST / ALT | Usually unchanged | Elevation is not considered physiologic. |
| Total bilirubin | Usually unchanged | Jaundice deserves prompt evaluation. |
| Alkaline phosphatase | Often increased, especially later pregnancy | Placental contribution limits specificity. |
| Albumin | Often decreased | Hemodilution is common. |
| PT/INR | Usually unchanged | Abnormal coagulation raises concern for severe hepatic dysfunction. |
2. Pattern-based approach +
>5 suggests hepatocellular injury, 2–5 suggests mixed injury, and <2 suggests cholestatic injury.
Pregnancy caution: ALP may rise from placental production, so the R-ratio may overcall cholestatic injury in later pregnancy.
Hepatocellular pattern: AST/ALT predominate. Think HELLP, AFLP, viral hepatitis, ischemic injury, drug-induced liver injury, chronic hepatitis, or autoimmune hepatitis.
Cholestatic pattern: Pruritus, bile acids, bilirubin, or cholestatic symptoms predominate. Think ICP, gallstones, biliary obstruction, medication effect.
Mixed pattern: Can occur with AFLP, severe HELLP, viral hepatitis, MASLD/NAFLD, alcohol-related liver disease, or multifactorial biliary disease.
| Pattern | Clues | Important considerations |
|---|---|---|
| Hepatocellular | Marked AST/ALT rise, especially into hundreds or thousands | HELLP, AFLP, viral hepatitis, ischemia, drug injury, chronic hepatitis, autoimmune hepatitis |
| Cholestatic | Pruritus, bile acids elevation, bilirubin, jaundice | ICP, gallstones, biliary obstruction, medication-associated cholestasis |
| Mixed | Both aminotransferase and cholestatic features | AFLP, severe HELLP, hepatitis, MASLD/NAFLD, alcohol-related disease, multifactorial disease |
3. Key pregnancy-specific disorders +
Intrahepatic Cholestasis of Pregnancy (ICP)
Typical presentation is pruritus with elevated total bile acids. Risk rises with more severe bile acid elevation. Total bile acids ≥100 µmol/L are associated with substantially increased fetal risk and commonly trigger discussion of delivery around 36 0/7 weeks in guideline-based management.
HELLP syndrome
Think HELLP with hypertension or preeclampsia features, elevated AST/ALT, thrombocytopenia, hemolysis, and elevated LDH. Severe headache, visual symptoms, RUQ pain, and severe-range blood pressure increase concern.
Acute Fatty Liver of Pregnancy (AFLP)
Usually a late pregnancy emergency. Concerning findings include nausea/vomiting, abdominal pain, jaundice, hypoglycemia, renal dysfunction, coagulopathy, encephalopathy, elevated bilirubin, and elevated ammonia. Swansea criteria are often used as supportive diagnostic criteria.
Hyperemesis gravidarum
Most often early pregnancy. Mild to moderate aminotransferase elevation may occur with severe nausea/vomiting and dehydration, but marked bilirubin elevation, coagulopathy, severe thrombocytopenia, or late-pregnancy disease suggests another process.
4. Important nonpregnancy diagnoses to remember +
Chronic liver disease categories
- NAFLD / MASLD may present with mild persistent AST/ALT elevation, metabolic risk factors, and steatotic appearance on imaging.
- Alcohol-related liver disease should remain on the differential when the pattern is compatible and the history supports exposure.
- Chronic hepatitis should be considered when aminotransferases remain elevated, especially if the pattern predates pregnancy or persists outside pregnancy-specific timing.
- Autoimmune hepatitis can present with hepatocellular injury and may need serologic workup and specialist review.
- Gallstones remain a practical nonpregnancy cause of RUQ pain and cholestatic or mixed liver test abnormalities.
5. Red flags that need urgent escalation +
- Severe-range blood pressure or preeclampsia signs with thrombocytopenia and elevated AST/ALT
- Hypoglycemia, coagulopathy, encephalopathy, or renal dysfunction suggesting AFLP
- AST or ALT into the thousands, raising concern for viral, toxic, or ischemic injury
- Fever, jaundice, and abdominal pain suggesting infection or biliary obstruction
6. Suggested workup checklist +
- CBC with platelets
- Comprehensive metabolic panel
- LDH
- Urine protein assessment
- PT/INR and fibrinogen if severe disease suspected
- Glucose and creatinine
- Total bile acids
- Peripheral smear, bilirubin fractionation, haptoglobin
- Hepatitis serologies if marked hepatocellular injury
- Acetaminophen level / medication review when indicated
- RUQ ultrasound if biliary disease suspected
- Consider chronic liver disease, autoimmune, and metabolic workup if the picture is persistent or atypical
Management by Diagnosis
Intrahepatic Cholestasis of Pregnancy (ICP)
Think ICP when the dominant picture is pruritus plus elevated total bile acids, often with mild to moderate aminotransferase elevation and without marked thrombocytopenia, severe hypoglycemia, or coagulopathy.
- Confirm and trend total bile acids and AST/ALT.
- Review symptom severity, especially nocturnal pruritus and palm/sole involvement.
- Exclude competing diagnoses if jaundice, fever, severe pain, or marked transaminase elevation is present.
- Consider fetal surveillance strategy based on gestational age and institutional practice.
- <40 µmol/L: lower-risk range.
- 40–99 µmol/L: increased concern; follow closely.
- ≥100 µmol/L: substantially higher fetal risk; many guideline-based pathways discuss delivery near 36 0/7 weeks.
HELLP Syndrome / Severe Preeclampsia-Related Liver Involvement
Think HELLP when abnormal LFTs occur with hypertension, thrombocytopenia, hemolysis evidence, headache, visual symptoms, RUQ pain, or elevated LDH.
- Assess maternal stability, blood pressure severity, neurologic symptoms, and fetal condition.
- Repeat CBC, CMP, LDH, creatinine, and hemolysis studies if evolving disease is suspected.
- Manage severe-range blood pressure promptly per institutional protocol.
- Consider magnesium sulfate when indicated for seizure prophylaxis.
- HELLP is commonly managed as an obstetric emergency.
- Delivery planning depends on gestational age, maternal condition, and fetal status.
- Postpartum worsening can occur, so short-interval reassessment is important even after delivery.
Acute Fatty Liver of Pregnancy (AFLP)
AFLP is a late-pregnancy emergency. Consider it when nausea/vomiting, abdominal pain, jaundice, hypoglycemia, renal dysfunction, coagulopathy, encephalopathy, or ammonia elevation cluster together.
- Admit urgently and reassess frequently.
- Repeat glucose, CBC, CMP, PT/INR, fibrinogen, creatinine, ammonia, and lactate as clinically indicated.
- Evaluate for encephalopathy, bleeding risk, renal injury, and worsening hepatic dysfunction.
- Use multidisciplinary care with MFM, anesthesia, ICU, blood bank, and hepatology as needed.
- AFLP is generally considered a delivery disease after maternal stabilization.
- Supportive care may include glucose management, blood product support, and correction of coagulopathy.
- Watch carefully postpartum, because hepatic and metabolic abnormalities may worsen before improving.
Viral, Toxic, or Ischemic Hepatitis
Marked hepatocellular injury, particularly AST or ALT above 1000 U/L, should broaden concern beyond pregnancy-specific disorders.
- Review medication, supplement, and acetaminophen exposure carefully.
- Consider hepatitis testing and additional serologies based on history and local protocol.
- Assess hemodynamics and consider ischemic injury when clinically appropriate.
- Trend bilirubin, INR, creatinine, mental status, and glucose.
- Jaundice, encephalopathy, INR elevation, or renal injury increase urgency.
- Rapidly rising aminotransferases or synthetic dysfunction warrant inpatient evaluation.
- Hepatology consultation may be helpful when diagnosis is uncertain or severe injury is present.
Biliary Obstruction / Gallbladder Disease
Suspect biliary disease when the picture includes RUQ pain, fever, jaundice, bilirubin elevation, or cholestatic symptoms, especially if bile acids are not the main abnormality.
- Obtain a focused history for colicky pain, fever, and prior gallstones.
- Consider RUQ ultrasound when obstruction, stones, or cholecystitis is suspected.
- Trend bilirubin, AST/ALT, ALP, and inflammatory markers as clinically appropriate.
- Fever plus RUQ pain plus jaundice suggests a more urgent biliary/infectious process.
- Persistent vomiting, sepsis concern, or worsening bilirubin should prompt escalation.
- Coordinate with surgery or gastroenterology when intervention is being considered.
Chronic / Nonpregnancy Liver Disease
When the pattern is milder, chronic, persistent, or not well explained by pregnancy-specific timing, broaden the differential to include NAFLD / MASLD, alcohol-related liver disease, chronic hepatitis, and autoimmune hepatitis.
- Mild persistent AST/ALT elevation without strong obstetric red flags
- Known chronic liver disease or abnormal pre-pregnancy liver tests
- Steatotic-appearing liver or metabolic syndrome pattern
- Ongoing unexplained hepatocellular injury despite negative pregnancy-specific workup
- Review prior liver test history and metabolic risk factors
- Consider hepatitis serologies and autoimmune evaluation as indicated
- Review alcohol and medication history carefully
- Consider hepatology consultation when the diagnosis remains unclear or the abnormality persists
Quiz Module
1. A patient at 33 weeks has intense pruritus and total bile acids of 46 µmol/L. Which diagnosis is most likely?
2. Which laboratory pattern is most supportive of HELLP syndrome?
3. Which finding is especially concerning for AFLP rather than uncomplicated ICP?
4. AST and ALT values above 1000 U/L should raise strong concern for:
5. Which nonpregnancy diagnosis is commonly associated with mild persistent aminotransferase elevation and metabolic risk factors?
6. RUQ pain with jaundice and fever should prompt particular concern for:
References and Source Notes
- Society for Maternal-Fetal Medicine (SMFM); Lee RH, Greenberg M, Metz TD, Pettker CM. Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic cholestasis of pregnancy. Am J Obstet Gynecol. 2021; reaffirmed 2024.
- Haram K, Mortensen JH, Nagy B. The HELLP syndrome: clinical issues and management. A Review. BMC Pregnancy Childbirth. 2009;9:8. PMID: 19245695.
- Sibai BM. Diagnosis, controversies, and management of the HELLP syndrome. Obstet Gynecol. 2004;103(5 Pt 1):981-991.
- Ch’ng CL, Morgan M, Hainsworth I, Kingham JGC. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut. 2002;51(6):876-880.
- Morton A, Laurie J. Physiological changes of pregnancy and the Swansea criteria in diagnosing acute fatty liver of pregnancy. Obstet Med. 2018;11(3):126-131. PMID: 30214478.
- Verma D, Duseja A. Systematic approach to pregnancy-specific liver disorders. Gastroenterol Hepatol (N Y). 2021;17(7):322-329. PMID: 34602893.
- Hay JE. Liver disease in pregnancy. Hepatology. 2008;47(3):1067-1076.
- Westbrook RH, Dusheiko G, Williamson C. Pregnancy and liver disease. J Hepatol. 2016;64(4):933-945.
- Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328-357.
- Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020;72(2):671-722.
- Goodwin TM. Hyperemesis gravidarum. Obstet Gynecol Clin North Am. 2008;35(3):401-417.
- Verberg MFG, Gillott DJ, Al-Fardan N, Grudzinskas JG. Hyperemesis gravidarum, a literature review. Hum Reprod Update. 2005;11(5):527-539.
The calculator’s support scores are heuristic educational weights based on commonly cited diagnostic features in obstetric and hepatology literature. They are not a validated clinical prediction model.